NCT03681483 2024-07-10
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
Memorial Sloan Kettering Cancer Center
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Tang-Du Hospital